ACLX Q2 2025 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-72.4% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$59M-777.4% margin

Net Income

-$53M-698.6% margin

EPS (Diluted)

$-0.94

QoQ Revenue Growth

-7.1%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$619M

Total Liabilities

$227M

Stockholders' Equity

$392M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$27M	-72.4%
Gross Profit	$8M	$26M	-71.1%
Operating Income	-$59M	-$35M	-67.8%
Net Income	-$53M	-$27M	-94.0%